人民卫生出版社系列期刊
ISSN 2096-2738 CN 11-9370/R

中国科技核心期刊(中国科技论文统计源期刊)
2020《中国学术期刊影响因子年报》统计源期刊

新发传染病电子杂志 ›› 2018, Vol. 3 ›› Issue (2): 111-114.

• 论著 • 上一篇    下一篇

初治单耐药肺结核的CT影像学研究

陈根铭1,3, 成官迅2, 朱少乾3, 曾令延3, 温兆意3, 庄燕妮3   

  1. 1.汕头大学医学院,广东 汕头 515041;
    2.北京大学深圳医院医学影像科,广东 深圳 518035;
    3.深圳市宝安区慢性病防治院放射科,广东 深圳 518102
  • 收稿日期:2017-10-15 出版日期:2018-05-30 发布日期:2020-06-29
  • 通讯作者: 成官迅,Email: chengguanxun@outlook.com
  • 基金资助:
    深圳市宝安区科技计划社会公益项目(2015313)

CT scanning of mono-resistant pulmonary tuberculosis during initial treatment

CHEN Gen-ming1,3, CHENG Guan-xun2, ZHU Shao-qian3, ZENG Ling-yan3, WEN Zhao-yi3, ZHUANG Yan-ni3   

  1. 1. Shangtou University Medical College, Shangtou 515041, China;
    2. Medical Imaging Department, Peking University Shenzhen Hospital,Shenzhen 518036,China Corresponding author;
    3. Department of Radiology,Baoan Chronic Diseases Prevent and Cure Hospital,Shenzhen 518102,China
  • Received:2017-10-15 Online:2018-05-30 Published:2020-06-29

摘要: 目的 探讨初治单耐药肺结核的CT表现及特点,以提高对初治单耐药肺结核的认识。方法 收集2015年7月至2017年12月深圳市宝安区慢性病防治院接诊的初治单耐药肺结核患者30例作为单耐药组,另选择同期初治抗结核药物敏感患者30例作为对照组,采用统计学软件分析两组在年龄、性别、病变分布及CT表现间的差异。结果 单耐药组与对照组在性别、病变分布差异上无显著性差异(P>0.05);单耐药组年龄较对照组小,有显著性差异(P<0.05);大叶样或段样实变、肺不张、无壁空洞及支气管壁增厚、管腔狭窄的出现率单耐药组均显著高于对照组(P<0.05);肺门纵隔淋巴结钙化的出现率显著低于对照组(P<0.05)。多因素logstic回归分析显示,大叶样或段样实变、无壁空洞、支气管壁增厚、管腔狭窄及无肺门纵隔淋巴结钙化为初治单耐药肺结核发生的主要危险因素。结论 初治单耐药肺结核CT表现以活动性征象为主,病变广泛,当存在大叶样或段样实变、无壁空洞、支气管增厚狭窄及无肺门纵隔淋巴结钙化等征象时,有助于初治单耐药肺结核的影像诊断。

关键词: 结核, 肺, 抗药物性, 计算机体层摄影术

Abstract: Objective To explore the CT manifestations and characteristics of mono-resistant pulmonary tuberculosis in the primary therapy,in order to raise awareness of mono-resistant pulmonary tuberculosis among population. Methods 30 patients with mono-resistant pulmonary in the primary therapy from Baoan Chronic Diseases Prevent and Cure Hospital between July 2015 and December 2017 were treatedas the mono-resistant group, and 30 patients with sensitive to anti tuberculosis drugs in the primary therapy during the same period were selected as the control group. The difference in age,gender,the distribution of lesions and CT manifestations in two groups were analyzed by statistical software. Results Chi square test showed that there was no significant difference in gender and disease distribution between the single drug resistance group and the control group (P>0.05),The age of single drug resistance group was smaller than that of the control group (P<0.05). The incidence of single drug resistance in large lobar or segment type, atelectasis, non-wall cavity and bronchial thickening was significantly higher than that of the control group (P<0.05), and the incidence of lymph node calcification in the mediastinal mediastinum was significantly lower than that of the control group (P<0.05). The incidence of calcification in mediastinal lymph nodes was significantly lower than that in the control group (P<0.05). Multifactor logistic regression analysis showed that large lobar or segmental consolidation, non-wall cavity, bronchial thickening and stenosis,non-calcification of hilum and mediastinal lymph nodes were the main risk factors for mono-resistant pulmonary tuberculosis in the primary therapy. Conclusion TheCT manifestations of mono-resistant pulmonary tuberculosis in the primary therapy are mainly active and extensive. When there are large lobar or segmental consolidation, non-wall cavity, bronchial thickening stenosis and non-calcification of hilum and mediastinal lymph nodes, it will be helpful for the diagnosis of mono-resistant pulmonary tuberculosis in the primary therapy.

Key words: Tuberculosis, pulmonary, Drug resistance, CT